CEO: John M. Leonard

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Intellia Therapeutics Inc is a gene editing company focused on the development of proprietary, potentially curative therapeutics utilizing a biological tool known as the CRISPR/Cas9 system.


Key numbers

Market Capitalization:650130600
Shares Outstanding: 48882000
Float: 37498262.076000005
Next Earning Date:2020-03-11
TTm EPS: -1.9636
TTm Dividend Rate:
200 days moving average:15.08
50 days moving average: 12.69
One day percent Change: 19.82



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,